Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Classical Hodgkin Lymphoma”

241 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 241 results

Testing effectiveness (Phase 2)Study completedNCT01118026
What this trial is testing

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 101
Testing effectiveness (Phase 2)Study completedNCT02824029
What this trial is testing

Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaRecurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
Barbara Ann Karmanos Cancer Institute 28
Testing effectiveness (Phase 2)Ended earlyNCT03947255
What this trial is testing

Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma

Who this might be right for
Hodgkin LymphomaPeripheral T Cell LymphomaAnaplastic Large Cell Lymphoma
Seagen Inc. 12
Testing effectiveness (Phase 2)Study completedNCT04052997
What this trial is testing

Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Relapsed Hodgkin LymphomaRefractory Hodgkin Lymphoma
ADC Therapeutics S.A. 117
Testing effectiveness (Phase 2)Study completedNCT00369681
What this trial is testing

Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Testing effectiveness (Phase 2)Looking for participantsNCT05404945
What this trial is testing

Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above

Who this might be right for
Classical Hodgkin Lymphoma
University of Virginia 44
Testing effectiveness (Phase 2)Looking for participantsNCT05723055
What this trial is testing

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Utah 9
Testing effectiveness (Phase 2)Ended earlyNCT01390584
What this trial is testing

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Who this might be right for
Lymphoma
ECOG-ACRIN Cancer Research Group 6
Not applicableStudy completedNCT03200977
What this trial is testing

Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab

Who this might be right for
Lymphoma
Bristol-Myers Squibb 95
Testing effectiveness (Phase 2)Study completedNCT03739619
What this trial is testing

Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Recurrent Hodgkin LymphomaRefractory Hodgkin LymphomaClassical Hodgkin Lymphoma+1 more
Emory University 3
Testing effectiveness (Phase 2)Study completedNCT02191930
What this trial is testing

Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 70
Testing effectiveness (Phase 2)Study completedNCT00654732
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma

Who this might be right for
Classic Hodgkin LymphomaLugano Classification Stage III Hodgkin Lymphoma AJCC v8Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8
M.D. Anderson Cancer Center 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06045195
What this trial is testing

Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 40
Early research (Phase 1)Study completedNCT03730363
What this trial is testing

Pentamidine + Salvage Chemo for Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaRefractory Hodgkin Lymphoma
Reinhold Munker 1
Not applicableStudy completedNCT05066555
What this trial is testing

Circulating Tumor DNA Genotyping for Biological Monitoring of Patients Treated in the FIL-Rouge Clinical Trial

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 100
Testing effectiveness (Phase 2)Study completedNCT01771107
What this trial is testing

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Who this might be right for
AIDS-Related Hodgkin LymphomaAnn Arbor Stage II Hodgkin LymphomaAnn Arbor Stage IIA Hodgkin Lymphoma+9 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT01660607
What this trial is testing

Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

Who this might be right for
Myeloid Leukemia, ChronicAcute Myelogenous LeukemiaMyelodysplastic Syndromes (MDS)+6 more
Stanford University 68
Early research (Phase 1)Ended earlyNCT01900496
What this trial is testing

Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Testing effectiveness (Phase 2)UnknownNCT04026269
What this trial is testing

Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen

Who this might be right for
Hodgkin Lymphoma
Han weidong 30
Large-scale testing (Phase 3)Looking for participantsNCT04638790
What this trial is testing

First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)

Who this might be right for
Hodgkin Lymphoma, Adult
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia 300
Load More Results